Item 1A. Risk Factors.

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The following table presents information with respect to the Company’s repurchases of its common stock during the quarter ended June 30, 2024:



Period	Total Number of Shares Purchased	Average Price Paid Per Share(1)		Total Number of Shares Purchased as Part of Publicly Announced Repurchase Plans or Programs	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions)(1)(2)
April 1 - April 30, 2024	—	$	—	—	$	547
May 1 - May 31, 2024	615,617	$	81.22	615,617	$	497
June 1 - June 30, 2024	119,120	$	83.95	119,120	$	487
Total for quarter ended June 30, 2024	734,737	$	81.66	734,737

(1)Excludes commissions cost.

(2)On August 18, 2021, the Company announced that its Board of Directors authorized a share repurchase program (the “Share Repurchase Program”) of up to $1,500 million of the Company's outstanding common stock. After giving effect to the share repurchases made through June 30, 2024 and as of such date, approximately $487 million Board authorization remained available. See Part II , Item 5 (Other Information) for additional information about the Company’s Share Repurchase Program.

Previous: Item 4. Controls and Procedures. · Next: Item 5. Other Information